Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Randomized Pilot Study of Early DAPT Discontinuation Based on Optical Coherence Tomography in High-Bleeding Risk Patients With Diabetes Mellitus Following Polymer-Free Amphilimus-Eluting Stent Implantation

NCT07238764 is registered in ClinicalTrials.gov with Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health as lead sponsor.

NCT NCT07238764
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07238764 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Randomized Pilot Study of Early DAPT Discontinuation Based on Optical Coherence Tomography in High-Bleeding Risk Patients With Diabetes Mellitus Following Polymer-Free Amphilimus-Eluting Stent Implantation
Lead sponsor
Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health
Phase
Not applicable
Overall status
Completed
Start date
June 12, 2022
Completion date
May 9, 2025
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, dapt(dual antiplatelet therapy), diabetes mellitus, high bleeding risk patients